Home | MyCME | All CME | Blog | Psychlopedia
​CME From JCP and PCC
Multimedia | CME From JCP | JCP Supplement | CME From PCC

CME From JCPHow common is illicit drug use among current and former cigarette smokers? If marijuana isn't considered illicit, does that change the prevalence of illicit drug use? Can illicit drug use interfere with smoking abstinence? Learn about these topics in this CME journal article. [top]

JCP CME Activities

Trends in Illicit Drug Use Among Smokers and Nonsmokers in the United States, 2002–2014

Scott J. Moeller, PhDa; David S. Fink, MPHb; Misato Gbedemah, MPHc; Deborah S. Hasin, Sandro Galea, Michael J. Zvolensky, and Renee D. Goodwin

Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis

Rakesh Jain, MD, MPH (Chair), and Christoph U. Correll, MD

Diagnosing and Treating Patients With Mixed Features

Rakesh Jain, MD, MPH (Chair), et al

Mindfulness-Based Stress Reduction for Older Adults With Stress Disorders and Neurocognitive Difficulties: A Randomized Controlled Trial

Julie Loebach Wetherell, Tamara Hershey, Steven Hickman, Susan R. Tate, David Dixon, Emily S. Bower, and Eric J. Lenze

Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive Disorder

Roger S. McIntyre, Trisha Suppes, Rajiv Tandon, and Michael Ostacher

Depression and Anxiety in the Postpartum Period and Risk of Bipolar Disorder: A Danish Nationwide Register-Based Cohort Study

Xiaoqin Liu, Esben Agerbo, Jiong Li, Samantha Meltzer-Brody, Veerle Bergink, and Trine Munk-Olsen

National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care

Donovan T. Maust, Frederic C. Blow, Ilse R. Wiechers, Helen C. Kales, and Steven C. Marcus

Adverse Childhood Experiences and Risk for First-Episode Major Depression During the Menopause Transition

Cynthia Neill Epperson, Mary D. Sammel, Tracy L. Bale, Deborah R. Kim, Sarah Conlin, Stephanie Scalice, Katharine Freeman, and Ellen W. Freeman

Identifying Remission From Depression on 3 Self-Report Scales

Mark Zimmerman, Emily Walsh, Michael Friedman, Daniela A. Boerescu, and Naureen Attiullah

Antipsychotic Drug Interactions and Mortality Among Nursing Home Residents With Cognitive Impairment

Rosa Liperoti, Federica Sganga, Francesco Landi, Eva Topinkova, Michael D. Denkinger, Henriëtte G. van der Roest, Andrea D. Foebel, Harriet Finne-Soveri, Roberto Bernabei, and Graziano Onder

Adherence to Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Prescriptions Affects Overall Medication Adherence in Older Persons: Evidence From the Italian Nationwide OsMed Health-DB Database

Alessandra Marengoni, Graziano Onder, Luca Degli Esposti, Pierluigi Russo, Diego Sangiorgi, Stefano Buda, Massimo Fini, Niccolò Marchionni, Stefano Bonassi, Federica Mammarella, Walter Marrocco, Giuseppe Pozzi, Katie Palmer, Alessandro Monaco, Sergio Pecorelli, Luca Pani, on behalf of the Geriatrics Steering Committee of the Italian Medicines Agency on behalf of the OsMed Health-DB Network

Medication Discrepancies at Outpatient Departments for Mood and Anxiety Disorders in the Netherlands: Risks and Clinical Relevance

Mirjam Simoons, Hans Mulder, Arne J. Risselada, Frederik W. Wilmink, Robert Schoevers, Henricus G. Ruhé, and Eric N. van Roon

Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial

Hitoshi Sakurai, Takefumi Suzuki, Robert R. Bies, Bruce G. Pollock, Masaru Mimura, Shitij Kapur, and Hiroyuki Uchida

The Perinatal Depression Treatment Cascade: Baby Steps Toward Improving Outcomes

Elizabeth Q. Cox, Nathaniel A. Sowa, Samantha E. Meltzer-Brody, and Bradley N. Gaynes

A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications

Samuel T. Wilkinson, Rajiv Radhakrishnan, and Deepak Cyril D’Souza

Nonmedical Stimulant Use in College Students: Association With Attention-Deficit/Hyperactivity Disorder and Other Disorders

Timothy Wilens, Courtney Zulauf, MaryKate Martelon, Nicholas R. Morrison, Andrew Simon, Nicholas W. Carrellas, Amy Yule, and Rayce Anselmo

Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States

Tulshi D. Saha, Bradley T. Kerridge, Risë B. Goldstein, S. Patricia Chou, Haitao Zhang, Jeesun Jung, Roger P. Pickering, W. June Ruan, Sharon M. Smith, Boji Huang, Deborah S. Hasin, and Bridget F. Grant

Improving the Diagnosis and Treatment of Adolescent Bipolar Disorder

Improving the Diagnosis and Treatment of Pediatric Bipolar Disorder

Robert L. Findling, MD, MBA (chair), and Kiki D. Chang, MD

Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice

Reconsidering Insomnia as a Disorder Rather Than Just a Symptom in Psychiatric Practice

Ruth M. Benca, MD, PhD, and Daniel J. Buysse, MD

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

Larry Culpepper, MD, MPH (Chair), et al

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment

Christoph U. Correll, MD (Chair), et al

CME From PCCHave you considered how conditions such as atopic dermatitis, acne, vitiligo, psoriasis, and alopecia affect your patients? Skin disease can be associated with anxiety, anger, depression, social isolation, and low self-esteem. Read this CME journal article to learn about recognizing and treating psychological problems in patients with skin diseases and communicating with patients in a culturally competent manner. [top]

PCC CME Activities

Psychiatric and Psychological Impact of Chronic Skin Disease

Mohammad Jafferany and Paul Pastolero

Psychological Aspects of Factitious Disorder

Mohammed Jafferany, Zaira Khalid, Katherine A. McDonald, and Amanda J Shelley

Are Psychiatric Inpatients at Risk of Developing Wernicke’s Encephalopathy Being Identified and Adequately Treated?

Medhat Guirguis, Stephen Manning, Marina Chavez, Jessica Nelson, Regina Baronia, Sailatha Bobba, Jafreen Ahmed, and Ijeoma Ajufo

Efficacy of a Behavioral Activation Teletherapy Intervention to Treat Depression and Anxiety in Primary Care VitalSign6 Program

Joseph M. Trombello, Charles South, Audrey Cecil, Katherine E. Sánchez, Alma Christina Sánchez, Sara Levinson Eidelman, Taryn L. Mayes, Farra Kahalnik, Corey Tovian, Beth D. Kennard, and Madhukar H. Trivedi

Mental and Physical Health Conditions in US Combat Veterans: Results From the National Health and Resilience in Veterans Study

Melissa M. Thomas, Ilan Harpaz-Rotem, Jack Tsai, Steven M. Southwick, and Robert H. Pietrzak

Mood Versus Memory

Anna D. Burke, William J. Burke, Garrett H. Riggs, David A. Weidman, and Jacquelynn N. Copeland

Long-Acting Injectable Antipsychotics for Schizophrenia: Sociodemographic Characteristics and Treatment Adherence

James McCreath, Essie Larson, Purabi Bharatiya, Hisham A. Labanieh, Zvi Weiss, and Michael Lozovatsky

Cardiometabolic Assessment, Diagnosis, and Treatment of Chronic Medical Illnesses During an Inpatient Psychiatric Hospitalization: Colocated Medical Care Versus Treatment as Usual

Jason R. Tatreau, Suzanne Harris, Brian Sheitman, and Beat D. Steiner

Bright Light Therapy as Augmentation of Pharmacotherapy for Treatment of Depression: A Systematic Review and Meta-Analysis

Thomas M. Penders, Cornel N. Stanciu, Alexander M. Schoemann, Phillip T. Ninan, Richard Bloch, and Sy A. Saeed

At a Loss for Words

David A. Weidman, Anna D. Burke, Garret H. Riggs, Helle Brand, Jacquelynn N. Copeland, and William J. Burke

Student Evaluation of the Yellow Ribbon Suicide Prevention Program in Midwest Schools

Alexandra Flynn, Rosalee Zackula, Nicole M. Klaus, Liz McGinness, Susan Carr, and Matthew Macaluso

​​​​​​​​​​​​​​​​​